Charles Chabal

Charles Chabal has extensive work experience in the medical field, particularly in pain management. Charles is currently the Chief Medical Officer for North America at Soovu Labs, Inc., where they are responsible for the development of targeted TRPV channel activators for pain and stress control. Prior to this role, they co-founded the company and served as the Chief Science Officer.

Chabal has also worked as an Anesthesiologist Volunteer at the Emergency Medical Services Authority (EMSA) California, providing support at COVID-19 field hospitals. Charles has held positions at Evergreen Hospital and Medical Center, where they worked as a Physician specializing in pain management and performed various procedures and treatments. Charles also served as the Director of the Evergreen Pain Management Center.

In addition, Chabal founded Talaria Inc., a research company that focused on pain assessment and outcomes tracking, language skills, and devices. Charles held the position of Founder and Chief Science Officer for over 20 years. Chabal has also been involved in leadership roles, such as serving as the President of the Washington Academy of Pain Management and as the Director of Pain Services at the VA Puget Sound Health Care System.

Charles has been affiliated with the University of Washington School of Medicine, starting as an Assistant Professor of Anesthesiology and later becoming an Associate Professor. Overall, Chabal has a diverse background in pain management, research, and leadership roles in the medical field.

Charles Chabal has a Bachelor's Degree in Biology Chemistry from West Virginia University. Charles then pursued a Doctor of Medicine (M.D.) from the University of Pittsburgh School of Medicine. Following that, they completed an Anesthesiology Residency Program at the University of Pittsburgh School of Medicine. Later, they attended the University of Washington for a Pain Medicine Fellowship Program, earning a Pain Management Fellowship.